Glucocorticoids unleash immune-dependent melanoma control through inhibition of the GARP/TGF-β axis
Charles H. Earnshaw, Poppy Dunn, Shih‐Chieh Chiang…·Santiago Zelenay
This study shows glucocorticoids enhance anti-tumor immunity by inhibiting the GARP/TGF-β axis in melanoma, improving prognosis and response to immunotherapy.